Transactions of the Royal Society of Tropical Medicine and Hygiene · 1995 · 144 citations · 6 references
Life SciencesInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyChemotherapyInfectious Disease PharmacotherapyAntiparasitic ChemotherapyAntiparasitic Drug ResistanceAntiparasitic PharmacologyAntiparasitic ResistanceMalariaParasite ControlAntimalarial AgentsAntimalarial Drug DevelopmentChemotherapy Of MalariaMalaria ChemoprophylaxisMalaria ResistancePlasmodium FalciparumPlasmodium VivaxTreatment Of Malaria
Fifty patients with Plasmodium vivax infection were treated with the standard regimen of chloroquine phosphate (1500 mg over 3 d) followed by primaquine (45 mg immediately and then weekly for 8 weeks); 43 patients had sensitive infections but recrudescences of parasitaemia occurred between days 3 and 14 with RI, RII and RIII patterns in one, 3 and 3 patients, respectively. All the chloroquine-resistant cases were again treated with chloroquine (1500 mg) and no further recrudescence or relapse was detected on days 21 and 28. This study indicates that chloroquine is losing its efficacy against P. vivax in Myanmar.
6
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Karl H. Rieckmann, Donald R. Davis, David C Hutton · The Lancet · 1989 · 519 citations
I. M. Rollo, L J Bruce-Chwatt · Journal of Parasitology · 1987 · 29 citations